Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies
暂无分享,去创建一个
[1] J. Staessen,et al. Angiotensin-Converting Enzyme Inhibitors and Calcium Channel Blockers for Coronary Heart Disease and Stroke Prevention , 2005, Hypertension.
[2] F. McAlister,et al. Re-examining the efficacy of β-blockers for the treatment of hypertension: a meta-analysis , 2006, Canadian Medical Association Journal.
[3] M. Law,et al. Headaches and the Treatment of Blood Pressure: Results From a Meta-Analysis of 94 Randomized Placebo-Controlled Trials With 24 000 Participants , 2005, Circulation.
[4] W. Elliott. Combination Therapy Versus Monotherapy in Reducing Blood Pressure: Meta-analysis on 11,000 Participants from 42 Trials , 2010 .
[5] D. Bennett,et al. Blood pressure and cardiovascular disease in the Asia Pacific region. , 2003, Journal of hypertension.
[6] B Neal,et al. Effects of different regimens to lower blood pressure on major cardiovascular events in older and younger adults: meta-analysis of randomised trials , 2008, BMJ : British Medical Journal.
[7] K. Schulz,et al. Sample size calculations in randomised trials: mandatory and mystical , 2005, The Lancet.
[8] R. Wood‐Baker,et al. Cardioselective beta-blockers for reversible airway disease. , 2002, The Cochrane database of systematic reviews.
[9] C. Wiysonge,et al. How strong is the evidence for use of beta-blockers as first-line therapy for hypertension? Systematic review and meta-analysis , 2006, Journal of hypertension.
[10] L. Stovner,et al. Prophylactic treatment of migraine with an angiotensin II receptor blocker: a randomized controlled trial. , 2003 .
[11] J. Staessen,et al. Blood Pressure Reduction and Cardiovascular Prevention: An Update Including the 2003–2004 Secondary Prevention Trials , 2005, Hypertension Research.
[12] N. Laird,et al. Meta-analysis in clinical trials. , 1986, Controlled clinical trials.
[13] Joel Gagnier,et al. The quality of randomized trial reporting in leading medical journals since the revised CONSORT statement. , 2005, Contemporary clinical trials.
[14] Peter Bacchetti,et al. Peer review of statistics in medical research: the other problem , 2002, BMJ : British Medical Journal.
[15] Jan A Staessen,et al. Cardiovascular protection and blood pressure reduction: a meta-analysis , 2001, The Lancet.
[16] Douglas G Altman,et al. Discrepancies in sample size calculations and data analyses reported in randomised trials: comparison of publications with protocols , 2008, BMJ : British Medical Journal.
[17] M. Pfeffer,et al. Blood pressure-dependent and independent effects of agents that inhibit the renin–angiotensin system , 2007, Journal of hypertension.
[18] J. Leonardi-Bee,et al. Sample Size Calculations in Acute Stroke Trials: A Systematic Review of Their Reporting, Characteristics, and Relationship With Outcome , 2004, Stroke.
[19] J. Williamson,et al. Health outcomes associated with calcium antagonists compared with other first-line antihypertensive therapies: a meta-analysis of randomised controlled trials , 2000, The Lancet.
[20] T. Raghunathan,et al. Diuretic therapy for hypertension and the risk of primary cardiac arrest. , 1994, The New England journal of medicine.
[21] C. Lewis,et al. Long-term effects on sexual function of five antihypertensive drugs and nutritional hygienic treatment in hypertensive men and women. Treatment of Mild Hypertension Study (TOMHS) , 1997, Hypertension.
[22] A. Hofman,et al. Thiazide Diuretics and the Risk for Hip Fracture , 2003, Annals of Internal Medicine.
[23] Thomas Lumley,et al. Health outcomes associated with various antihypertensive therapies used as first-line agents: a network meta-analysis. , 2003, JAMA.
[24] D. Hewitt,et al. A survey of childhood malignancies. , 1962, British medical journal.
[25] M. Duke. Thiazide-lnduced Hypokalemia: Association With Acute Myocardial Infarction and Ventricular Fibrillation , 1978 .
[26] J. Bosch,et al. Serum potassium, cardiovascular risk, and effects of an ACE inhibitor: results of the HOPE study. , 2005, Clinical nephrology.
[27] Daniel W. Jones,et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. , 2003, JAMA.
[28] L. Lindholm,et al. Atenolol in hypertension: is it a wise choice? , 2004, The Lancet.
[29] G. Bakris,et al. Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients. , 2008, The New England journal of medicine.
[30] Morris J. Brown,et al. British Hypertension Society guidelines for hypertension management 2004 (BHS-IV): summary , 2004, BMJ : British Medical Journal.
[31] David Moher,et al. Peer review of statistics in medical research. Reporting power calculations is important. , 2002, BMJ.
[32] V. Roger,et al. The incidence of stroke after myocardial infarction: a meta-analysis. , 2006, The American journal of medicine.
[33] W. Willett,et al. A prospective study of thiazide use and fractures in women , 2005, Osteoporosis International.
[34] S. Verma,et al. Angiotensin receptor blockers and myocardial infarction , 2004, BMJ : British Medical Journal.
[35] J. Staessen,et al. Blood Pressure Lowering for Primary and Secondary Prevention of Stroke , 2006, Hypertension.
[36] M. Law,et al. Calcium channel blockers and headache. , 2007, British journal of clinical pharmacology.
[37] W. Elliott,et al. The Role of Calcium Antagonists in Stroke Prevention , 2005, Journal of clinical hypertension.
[38] R. Collins,et al. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies , 2002, The Lancet.
[39] A. Hofman,et al. Diuretics, -Blockers, and the Risk for Sudden Cardiac Death in Hypertensive Patients , 1995, Annals of Internal Medicine.
[40] B Neal,et al. Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials , 2000, The Lancet.
[41] B. W. East,et al. Relation of arrhythmias and electrolyte abnormalities to survival in patients with severe chronic heart failure. , 1987, Circulation.
[42] V. Roger,et al. The incidence of ischemic stroke in chronic heart failure: a meta-analysis. , 2007, Journal of cardiac failure.
[43] N J Wald,et al. Value of low dose combination treatment with blood pressure lowering drugs: analysis of 354 randomised trials , 2003, BMJ : British Medical Journal.
[44] Morris J. Brown,et al. Influence of drugs and gender on the arterial pulse wave and natriuretic peptide secretion in untreated patients with essential hypertension. , 2002, Clinical science.
[45] P. Poole‐Wilson,et al. Diuretic-induced potassium and magnesium deficiency: relation to drug-induced QT prolongation, cardiac arrhythmias and sudden death. , 1992, Journal of hypertension.
[46] M. Duke. Thiazide-induced hypokalemia. Association with acute myocardial infarction and ventricular fibrillation. , 1978, JAMA.
[47] G. Chrysant,et al. The Pleiotropic Effects of Angiotensin Receptor Blockers , 2006, Journal of clinical hypertension.
[48] R. Collins,et al. Blood pressure, stroke, and coronary heart disease Part 2, short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context , 1990, The Lancet.
[49] M. Kendall,et al. -Blockers and Sudden Cardiac Death , 1996, Annals of Internal Medicine.
[50] D. Moher,et al. The Revised CONSORT Statement for Reporting Randomized Trials: Explanation and Elaboration , 2001, Annals of Internal Medicine.
[51] L. Stovner,et al. Prophylactic treatment of migraine with angiotensin converting enzyme inhibitor (lisinopril): randomised, placebo controlled, crossover study , 2001, BMJ : British Medical Journal.
[52] S. Hernández-Díaz,et al. Major congenital malformations after first-trimester exposure to ACE inhibitors. , 2006, The New England journal of medicine.
[53] A. LaCroix,et al. Low-Dose Hydrochlorothiazide and Preservation of Bone Mineral Density in Older Adults , 2000, Annals of Internal Medicine.
[54] R Smith,et al. PubMed Central: creating an Aladdin's cave of ideas , 2001, BMJ : British Medical Journal.
[55] N J Wald,et al. Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis , 2003, BMJ : British Medical Journal.
[56] A. Dominiczak,et al. 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) , 2007, European heart journal.
[57] J. Staessen,et al. Cardiovascular prevention and blood pressure reduction: a quantitative overview updated until 1 March 2003 , 2003, Journal of hypertension.
[58] M. Domanski,et al. Diuretics and risk of arrhythmic death in patients with left ventricular dysfunction. , 1999, Circulation.
[59] L. Poston,et al. British Hypertension Society guidelines for hypertension management 1999: summary , 1999, BMJ.
[60] G. Flaker,et al. Hypokalemia as a cause of cardiac arrest: results of electrophysiologic testing and long-term follow-up. , 1985, American heart journal.
[61] Gordon H Guyatt,et al. In the Era of Systematic Reviews, Does the Size of an Individual Trial Still Matter? , 2008, PLoS medicine.
[62] D. Wald,et al. Combination Therapy Versus Monotherapy in Reducing Blood Pressure: Meta-analysis on 11,000 Participants from 42 Trials , 2010 .
[63] C. Meinert,et al. Content of reports on clinical trials: a critical review. , 1984, Controlled clinical trials.
[64] M. Bracken. Major Congenital Malformations after First-Trimester Exposure to ACE Inhibitors , 2007 .
[65] Neil Chapman,et al. Effects of different blood pressure-lowering regimens on major cardiovascular events in individuals with and without diabetes mellitus: results of prospectively designed overviews of randomized trials. , 2005, Archives of internal medicine.
[66] W. Ray,et al. Pregnancy Outcome Following Exposure to Angiotensin‐Converting Enzyme Inhibitors , 1992, Obstetrics and gynecology.
[67] D. Moher,et al. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. , 2001, Annals of internal medicine.
[68] J. Neoptolemos,et al. Early prediction of severity in acute pancreatitis by urinary trypsinogen activation peptide: a multicentre study , 2000, The Lancet.
[69] M. Law,et al. Lowering blood pressure to prevent myocardial infarction and stroke: a new preventive strategy. , 2003, Health technology assessment.
[70] F. Zacharias. Beta blockers in hypertension. , 1973, Bruxelles medical.
[71] M E Safar,et al. Improvement in Blood Pressure, Arterial Stiffness and Wave Reflections With a Very-Low-Dose Perindopril/Indapamide Combination in Hypertensive Patient: A Comparison With Atenolol , 2001, Hypertension.
[72] F. Turnbull. Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials , 2003, The Lancet.
[73] Alice Stanton,et al. Differential Impact of Blood Pressure–Lowering Drugs on Central Aortic Pressure and Clinical Outcomes: Principal Results of the Conduit Artery Function Evaluation (CAFE) Study , 2006, Circulation.
[74] L. Lindholm,et al. Should β blockers remain first choice in the treatment of primary hypertension? A meta-analysis , 2005, The Lancet.
[75] J. Kjekshus,et al. -Blockers and Sudden Cardiac Death , 1995, Annals of Internal Medicine.
[76] Daniel W. Jones,et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. , 2003, JAMA.
[77] R. Collins,et al. Blood pressure, stroke, and coronary heart disease Part 1, prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias , 1990, The Lancet.
[78] Andrew J Vickers,et al. Underpowering in randomized trials reporting a sample size calculation. , 2003, Journal of clinical epidemiology.
[79] Sonia S Anand. Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis. Law MR, Wald NJ, Rudnicka AR. BMJ 2003; 326: 1407-408. , 2003, Vascular medicine.
[80] D. Warner,et al. Statistical power, sample size, and their reporting in randomized controlled trials , 1995 .